A fourfold increase of oesophageal variceal bleeding in cirrhotic patients with a history of oesophageal variceal bleeding.

Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant (2007) 4.50

Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant (2010) 3.48

The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33

The treatment of portal hypertension: a meta-analytic review. Hepatology (1995) 3.11

Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology (2010) 2.77

Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology (2004) 1.78

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med (1991) 1.64

Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut (2008) 1.56

Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data. BMC Health Serv Res (2007) 1.41

The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors. Am J Gastroenterol (2012) 1.16

Hepatitis-B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells. Cancer (1983) 1.13

Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study. Gut (2011) 1.12

A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. J Hepatol (1993) 1.11

Effect of renal impairment on mortality of patients with cirrhosis and spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol (2012) 1.08

Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhage. Dig Dis Sci (2008) 0.95

Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients. Liver Int (2012) 0.92

Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices. Aliment Pharmacol Ther (2010) 0.90

Non-adherence to antibiotic prescription guidelines in treating urinary tract infection of children: a population-based study in Taiwan. J Eval Clin Pract (2010) 0.84

Independent factors associated with early outcome in Chinese cirrhotic patients after cessation of initial esophageal variceal hemorrhage. J Clin Gastroenterol (2010) 0.82

Potential precipitating factors of esophageal variceal bleeding: a case-control study. Am J Gastroenterol (2010) 0.81

The Effect of the First Spontaneous Bacterial Peritonitis Event on the Mortality of Cirrhotic Patients with Ascites: A Nationwide Population-Based Study in Taiwan. Gut Liver (2016) 0.78

The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Follow-up Study. PLoS One (2016) 0.77

Mortality Following Catheter Drainage Versus Thoracentesis in Cirrhotic Patients with Pleural Effusion. Dig Dis Sci (2017) 0.75